VENUS REMEDIES LIMITED (VENUSREM)

NSE: ₹1,555.80
BSE: ₹1,559.15
Stock Performance
Corporate Announcements

Quarterly Financials

Consolidated Standalone
Particulars Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
Revenue from Operations 167.72 143.42 195.16 108.61 167.45 176.86 194.97 131.90 192.75 180.26 259.40 178.86
YOY Revenue Growth % 19.89% 22.69% 25.39% 14.15% -0.16% 23.32% -0.1% 21.44% 15.11% 1.92% 33.05% 35.6%
Other Income 3.05 2.35 3.92 1.59 10.58 2.03 6.76 8.69 1.71 2.52 4.95 2.62
Total Income 170.77 145.77 199.08 110.20 178.03 178.89 201.73 140.59 194.46 182.78 264.35 181.48
Total Expenses + 156.43 137.99 181.62 103.35 168.96 163.92 170.69 127.98 167.97 149.31 202.75 151.44
Cost of Materials Consumed 95.17 87.31 84.17 69.58 77.46 97.52 104.21 71.33 106.51 93.86 116.28 83.14
Employee Benefit Expense 18.51 17.35 19.71 18.21 21.57 19.55 21.16 20.30 22.97 20.83 24.56 23.37
Other Expenses 33.90 24.84 35.94 21.51 33.24 28.75 41.75 27.34 31.51 35.66 51.86 37.02
Operating Profit 11.29 5.43 13.55 5.26 -1.51 12.94 24.28 3.92 24.78 30.95 56.65 27.42
OPM % 6.7% 3.8% 6.9% 4.8% -0.9% 7.3% 12.5% 3% 12.9% 17.2% 21.8% 15.3%
Profit Before Tax + 14.34 7.78 17.47 6.85 9.08 24.88 31.04 12.61 26.49 33.47 61.60 30.04
Tax Expense 4.40 0.93 6.96 5.63 5.56 5.28 10.04 3.01 6.36 7.89 14.11 7.07
Tax % 30.7% 12% 39.9% 82.2% 61.3% 21.2% 32.3% 23.9% 24% 23.6% 22.9% 23.5%
Profit After Tax 9.94 6.85 10.51 1.22 3.52 19.60 21.00 9.60 20.13 25.58 47.49 22.97
EPS (Basic) 7.44 5.13 7.86 0.92 2.63 14.66 15.71 7.18 15.06 19.14 35.53 17.18

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020
Revenue from Operations 769.60 647.89 601.45 555.51 598.65 548.12 341.46
YOY Revenue Growth % 18.79% 7.72% 8.27% -7.21% 9.22% 60.52% -
Other Income 12.58 20.96 11.58 10.32 8.31 19.63 5.31
Total Income 782.18 668.85 613.03 565.83 606.96 567.75 346.77
Total Expenses + 648.03 606.93 568.38 527.90 570.55 542.64 294.79
Cost of Materials Consumed 387.98 348.77 344.28 317.79 381.97 347.94 168.46
Employee Benefit Expense 88.68 80.49 71.50 61.33 52.33 46.02 46.02
Other Expenses 146.37 125.24 115.66 102.99 98.76 107.54 80.31
Operating Profit 121.57 40.96 33.07 27.61 28.10 5.48 46.67
OPM % 15.8% 6.3% 5.5% 5% 4.7% 1% 13.7%
Profit Before Exceptional 134.15 61.92 44.65 37.93 36.41 25.11 0.78
Exceptional Items 0.00 9.91 0.00 0.00 0.00 23.44 -8.81
Profit Before Tax + 134.15 71.83 44.65 37.93 36.41 48.55 -8.03
Tax Expense 31.37 26.51 16.15 11.36 -4.32 -13.21 1.96
Tax % 23.4% 36.9% 36.2% 29.9% -11.9% -27.2% -
Profit After Tax 102.78 45.32 28.50 26.57 40.72 61.77 -10.00
EPS (Basic) 76.89 33.90 21.31 19.88 30.86 50.04 -8.10

Balance Sheet

Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020
ASSETS
Non-Current Assets + 458.50 264.00 267.30 278.12 301.78 324.26 0.00
Property, Plant & Equipment 125.43 124.70 133.32 136.72 153.01 164.97 0.00
Capital Work in Progress 51.36 26.39 21.08 26.10 25.23 25.11 0.00
Non-Current Investments 163.82 0.00 0.00 0.00 0.00 0.00 0.00
Goodwill 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other Intangible Assets 93.98 0.00 85.21 79.24 87.93 96.72 0.00
Current Assets + 395.21 451.72 359.53 322.96 278.04 231.60 0.00
Inventories 129.37 100.49 121.69 119.94 125.64 119.99 0.00
Trade Receivables 103.28 112.22 80.50 76.66 38.60 32.04 0.00
Cash and Cash Equivalents 25.12 57.52 48.96 21.21 43.26 28.88 0.00
Current Investments 73.80 84.09 19.09 20.13 0.00 0.00 0.00
LIABILITIES & EQUITY
Total Equity 663.75 560.95 487.55 460.34 440.45 400.28 0.00
Equity Share Capital 13.37 13.37 13.37 13.37 13.37 12.34 0.00
Other Equity 650.38 547.58 474.18 446.97 427.08 387.94 0.00
Non-Current Liabilities 28.20 18.48 59.86 58.17 46.63 58.13 0.00
Current Liabilities 161.76 136.29 79.42 82.57 92.74 97.44 0.00
Total Liabilities 189.96 154.77 139.28 140.74 139.37 155.57 0.00

Cash Flow Statement

Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020
Cash from Operating Activities 155.76 86.45 37.28 36.62 41.00 132.61 0.00
Cash from Investing Activities -181.56 -76.25 -7.21 -50.83 -16.63 55.72 0.00
Cash from Financing Activities -3.12 -1.02 -1.08 -0.57 -9.48 -162.24 0.00
Net Increase/Decrease in Cash -32.41 8.56 27.74 -22.05 14.38 26.09 0.00